How often should a patient with diabetes taking Lantus (insulin glargine) check their blood glucose levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Glucose Monitoring Frequency with Lantus (Insulin Glargine)

Patients on Lantus should check their blood glucose at minimum once daily (fasting glucose every morning) to guide basal insulin dose adjustments, but most patients on intensive insulin regimens require 6-10 checks daily including before meals and snacks, at bedtime, occasionally postprandially, prior to exercise, when suspecting hypoglycemia, after treating hypoglycemia until normoglycemic, and before critical tasks like driving. 1, 2

For Type 1 Diabetes or Intensive Insulin Regimens (Lantus + Rapid-Acting Insulin)

Minimum 6-10 glucose checks daily are required for most patients, with testing at the following times: 1, 2

  • Before each meal and snack - to guide prandial insulin dosing 1
  • At bedtime - to assess overnight insulin needs and prevent nocturnal hypoglycemia 1, 2
  • Occasionally postprandially (2 hours after meals) - to assess meal coverage 2, 3
  • Prior to exercise - to prevent exercise-induced hypoglycemia 1, 2
  • When suspecting hypoglycemia - and continue checking after treatment until normoglycemic 1, 2
  • Before critical tasks such as driving 1, 2

The frequency of 6-10 daily checks is associated with better glycemic control, with each additional daily check reducing A1C by approximately 0.2% (leveling off at five tests per day). 1, 2

For Type 2 Diabetes on Lantus Plus Oral Medications (No Prandial Insulin)

Check fasting blood glucose every morning as the primary determinant for adjusting basal insulin doses, since it directly reflects overnight insulin coverage. 4, 5

Add one additional reading daily, preferably 2-hour postprandial, which paired with premeal concentrations provides an index of glycemic excursion. 4

While optimal frequency for patients on basal insulin with oral agents has not been definitively established, assessing fasting glucose with blood glucose monitoring to inform dose adjustments results in lower A1C. 1, 4

Critical Situations Requiring Increased Monitoring

Check glucose every 15 minutes after treating hypoglycemia (<70 mg/dL) with 15-20g of fast-acting carbohydrate, and repeat treatment if still hypoglycemic. 3

Increase monitoring frequency during: 3

  • Dose adjustments or therapy changes
  • Acute illness
  • Changes in routine, exercise, or meal patterns

Common Pitfalls to Avoid

Never rely solely on A1C testing without regular home glucose monitoring - A1C does not provide information about glycemic variability or hypoglycemia, and home glucose readings confirm meter accuracy. 1, 4

Suspect inaccurate readings if home blood glucose tests are inconsistent with A1C testing - faulty meters or test strips can provide grossly inaccurate readings. 1, 4

Use only FDA-approved glucose meters with unexpired test strips purchased from a pharmacy or licensed distributor to ensure accuracy while avoiding counterfeit products. 2, 4

Be aware of interfering factors - hematocrit levels, high-dose vitamin C, hypoxemia, and certain sugars (maltose, galactose, xylose) can affect glucose meter accuracy. 2, 3

Timing Flexibility with Lantus Administration

Lantus can be administered before breakfast, before dinner, or at bedtime with similar glycemic control, though morning administration is associated with significantly fewer nocturnal hypoglycemia episodes (59.5% of patients) compared to dinner (71.9%) or bedtime (77.5%) administration. 6

Regardless of administration time, fasting glucose measured the following morning remains the key metric for basal insulin dose titration. 3, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Timing of Capillary Blood Glucose Monitoring

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Blood Glucose Monitoring and Insulin Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Blood Glucose Monitoring for Patients on Basal Insulin and Metformin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the appropriate increase in the Lantus (insulin glargine) dose for a patient with diabetes, currently taking 16 units, who has a morning blood glucose level of 240 mg/dL?
Do you order blood sugar checks for a patient on Lantus (insulin glargine) with a history of hypoglycemia?
How to adjust Lantus (insulin glargine) dose for a patient with Type 2 diabetes and hyperglycemia?
What is the initial bedtime dose of Lantus (insulin glargine) for a patient with hyperglycemia (blood sugar levels of 300-500 mg/dL)?
Should the Lantus (insulin glargine) dose be increased to 5 units daily given a current FBG of 260?
What are the best augmentation options for a patient with anxiety and depression who is still experiencing symptoms while taking 15mg of Lexapro (escitalopram)?
Can a patient with bipolar disorder, anxiety, and depression, currently taking lurasidone, hydroxyzine, amitriptyline, and sumatriptan, use lamictal (lamotrigine)?
What is the best treatment approach for a 24-week pregnant patient with a sinus infection?
How would you manage hyponatremia in an elderly woman with a history of myocardial infarction (heart attack) and diet-controlled diabetes mellitus, presenting with pneumonia, confusion, and lab results showing severe hyponatremia?
What are the causes and treatment options for persistent hand numbness, potentially related to conditions like diabetes or peripheral neuropathy?
What is the appropriate diagnosis and management for a patient with sudden onset of pain in the popliteal region?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.